What we do.
Starton Therapeutics is a clinical-stage biotechnology company focused on improving standard-of-care therapies with our proprietary platform of continuous delivery technology systems to deliver superior outcomes.
We transform FDA-approved active ingredients and leverage our continuous delivery systems to establish improved pharmacokinetic (PK) profiles for existing approved drugs. Our platform technology enables lower but longer drug exposure and the potential to bring products to market in either new indications or with superior outcomes in existing indications.
We develop in parallel subcutaneous, oral and transdermal delivery systems. With multiple delivery methods in development, Starton can expand the number of medicines it is able to deliver continuously, based on patients’ individualized needs and provide multiple avenues for success.
Latest News
